Business Context and Reporting Period
Company: Health In Tech, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 15, 2025
Reporting Period: Specific event date of August 15, 2025.
Context: The filing discloses the approval and grant of restricted stock awards (RSAs) to three named executive officers in connection with the development of two new initiatives, designated as "Program 1" and "Program 2."
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes
The material change reported is the approval by the Compensation Committee of the Board of Directors to grant RSAs to the following executives under the Health In Tech, Inc. Equity Incentive Plan:
- Tim Johnson (CEO): 17,000 shares for Program 1 and 17,000 shares for Program 2 (Total: 34,000 shares).
- Linlin (Julia) Qian (CFO): 10,000 shares for Program 1 and 17,000 shares for Program 2 (Total: 27,000 shares).
- (Mo) Imran Yousuf (CTO): 3,500 shares for Program 1 and 3,500 shares for Program 2 (Total: 7,000 shares).
Guidance, Outlook, and Vesting Terms
Vesting Schedule: The RSAs are subject to performance-based vesting tied to the successful launch and full operational status of the Programs in the marketplace.
- First 50%: Vests in equal monthly installments over 12 months commencing on the date the first of the two Programs is successfully launched.
- Remaining 50%: Vests in equal monthly installments over 12 months commencing on the date the other Program is successfully launched.
Outlook: The filing indicates active development of two new programs but provides no specific financial guidance, revenue projections, or timelines for launch dates.
Investor Verification Checklist
- Verify the current market price of Class A Common Stock (Symbol: HIT) to calculate the potential dilution and value of the 68,000 total shares granted.
- Review the specific terms of the "Restricted Stock Award Agreements" referenced in the filing for additional forfeiture conditions.
- Monitor future filings for announcements regarding the successful launch and operational status of "Program 1" and "Program 2" to determine vesting commencement dates.
- Confirm the total authorized share count under the Health In Tech, Inc. Equity Incentive Plan to assess remaining capacity for future grants.